Semi-Annual Statement Of Income

Kringle Pharma,Inc. - Filing #7338974

Concept 2023-10-01 to
2024-03-31
2022-10-01 to
2023-03-31
Semi-annual statement of income
Statement of income
Net sales
43,029,000 JPY
34,353,000 JPY
Cost of sales
JPY
JPY
Ordinary profit (loss)
-365,471,000 JPY
-314,811,000 JPY
Gross profit (loss)
43,029,000 JPY
34,353,000 JPY
Selling, general and administrative expenses
409,776,000 JPY
349,287,000 JPY
Selling, general and administrative expenses
Profit (loss) before income taxes
-365,471,000 JPY
-314,811,000 JPY
Operating profit (loss)
-366,746,000 JPY
-314,934,000 JPY
Income taxes - current
746,000 JPY
745,000 JPY
Non-operating income
1,275,000 JPY
188,000 JPY
Non-operating income
Interest income
7,000 JPY
5,000 JPY
Income taxes
746,000 JPY
745,000 JPY
Non-operating expenses
JPY
65,000 JPY
Profit (loss)
-366,217,000 JPY
-315,557,000 JPY
Non-operating expenses

Talk to a Data Expert

Have a question? We'll get back to you promptly.